Type 2 Diabetes

Latest News


CME Content


The 74th Scientific Sessions of the American Diabetes Association (ADA) brought together more than 17,300 attendees from more than 121 countries. This year's program included 96 symposia, 50 oral abstract sessions, 10 interest group discussions, 18 meet-the-expert sessions, and 10 special lectures and addresses. Cardiology Review is covering 6 of the top sessions.

Truths about necrobiosis lipoidica, advantages of SGLT2 inhibitors, rash in an obese teen, benefits of insulin therapy, knee effusions with diabetes and hypertension-these questions about diabetes put your knowledge to the test.

Empagliflozin is the third sodium-glucose cotransporter 2 inhibitor approved for use in the US. There is a lot to learn about this new class. Here, 5 of the many things you need to know.

Premixed insulin--a basal and prandial product delivered in one injection--sounds like an ideal solution for patients who resist multidose insulin therapy. For some it is, but not for all. A case and the caveats, here.

A 36-year-old pregnant woman at 27 weeks gestation presented to the obstetrical triage for evaluation of possible abscess due to a lesion on her buttock that first appeared 1 week ago. Since that time, it has become increasingly painful and itchy. Although she denies any systemic symptoms, her pregnancy is complicated by gestational diabetes and obesity. However, she is HIV negative and her other prenatal labs were unremarkable.